Trials / Conditions / Hyperlipoproteinemia (a)
Hyperlipoproteinemia (a)
4 registered clinical trials studyying Hyperlipoproteinemia (a) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of SRSD216 in Patients With Elevated Lipoprotein (a) NCT07172646 | Sirius Therapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) NCT05900141 | Novartis Pharmaceuticals | Phase 3 |
| Completed | A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of We NCT05305664 | Novartis Pharmaceuticals | Phase 3 |
| Withdrawn | Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a) NCT01064934 | Charite University, Berlin, Germany | N/A |